TY - JOUR
T1 - Comparison of antibiotics use, urinary tract infection (UTI)-causative bacteria and their antibiotic susceptibilities among 4 hospitals with different backgrounds and regions in Japan
AU - Shigemura, Katsumi
AU - Kitagawa, Koichi
AU - Osawa, Kayo
AU - Yamamichi, Fukashi
AU - Tokimatsu, Issei
AU - Nomi, Masashi
AU - Takaba, Kei
AU - Fujisawa, Masato
N1 - Publisher Copyright:
© 2017 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.
PY - 2018/1/2
Y1 - 2018/1/2
N2 - In this study, we compared the antibiotic use, urinary tract infection-causative bacteria and their antibiotic susceptibilities among four hospitals with different backgrounds and regions in Japan in 2014. Frequency of antibiotic use (antibiotic use density: AUD/all AUD) were: ampicillin: 0.21–20.3 (median: 1.6) and cefazolin: 0.8–34.2 (2.5), representatively. The antibiotic resistant rates of Escherichia coli were ampicillin: 1.1–52.3% (median: 51.8%), piperacillin: 47.9–49.1% (48.0%), cefazolin: 23.2–34.1% (28.9%), levofloxacin: 36.6–43.8% (40.2%).We found that there were significant correlations (1) between antibiotic resistance of E. coli and annual total amount of antibiotic use (p = 0.017), annual number of days of antibiotic use (p = 0.002) and days of therapy (DOT, p = 0.002), and (2) between antibiotic resistance of extended-spectrum β-lactamase-producing bacteria and annual number of days of antibiotic use (p = 0.004) and DOT (p = 0.004) in a rehabilitation hospital. These results suggested that more antibiotic uses could lead to antibiotic resistances. Further analyses with more number of data are being undertaken.
AB - In this study, we compared the antibiotic use, urinary tract infection-causative bacteria and their antibiotic susceptibilities among four hospitals with different backgrounds and regions in Japan in 2014. Frequency of antibiotic use (antibiotic use density: AUD/all AUD) were: ampicillin: 0.21–20.3 (median: 1.6) and cefazolin: 0.8–34.2 (2.5), representatively. The antibiotic resistant rates of Escherichia coli were ampicillin: 1.1–52.3% (median: 51.8%), piperacillin: 47.9–49.1% (48.0%), cefazolin: 23.2–34.1% (28.9%), levofloxacin: 36.6–43.8% (40.2%).We found that there were significant correlations (1) between antibiotic resistance of E. coli and annual total amount of antibiotic use (p = 0.017), annual number of days of antibiotic use (p = 0.002) and days of therapy (DOT, p = 0.002), and (2) between antibiotic resistance of extended-spectrum β-lactamase-producing bacteria and annual number of days of antibiotic use (p = 0.004) and DOT (p = 0.004) in a rehabilitation hospital. These results suggested that more antibiotic uses could lead to antibiotic resistances. Further analyses with more number of data are being undertaken.
KW - Antibiotic susceptibilities
KW - Antibiotic use
KW - Causative bacteria
KW - Multicentre study
KW - Urinary tract infection
UR - https://www.scopus.com/pages/publications/85030160018
U2 - 10.1080/1120009X.2017.1376817
DO - 10.1080/1120009X.2017.1376817
M3 - 記事
C2 - 28956738
AN - SCOPUS:85030160018
SN - 1120-009X
VL - 30
SP - 31
EP - 36
JO - Journal of Chemotherapy
JF - Journal of Chemotherapy
IS - 1
ER -